Showing results (11-20 of 91) with videos related to

Sort By:
Pageof 10
Diabetes, Obesity & Metabolism|February 13, 2018
Dulaglutide 1.5 mg as an add-on option for patients uncontrolled on insulin: Subgroup analysis by age, duration of diabetes and baseline glycated haemoglobin concentrationKevin M Pantalone, Hiren Patel, Maria Yu, et al.
Clinical Therapeutics|October 9, 2021
The Health Care Resource Utilization and Costs Among Patients With Type 2 Diabetes and Either Cardiovascular Disease or Cardiovascular Risk Factors An Analysis of a US Health Insurance DatabaseJuliana Meyers, Meredith Hoog, Reema Mody, et al.
Diabetes, Obesity & Metabolism|September 18, 2020
Adherence and persistence among patients with type 2 diabetes initiating dulaglutide compared with semaglutide and exenatide BCise: 6-month follow-up from US real-world dataReema Mody, Maria Yu, Bal Nepal, et al.
Singapore Medical Journal|October 3, 2014
Back pain in patients with severe osteoporosis on teriparatide or antiresorptives: a prospective observational study in a multiethnic populationThawee Songpatanasilp, Malik Mumtaz, Harvinder Chhabra, et al.
Journal of Water and Health|January 31, 2024
Impact of sample acidification and extract storage on hormone receptor-mediated and oxidative stress activities in wastewaterMaria Yu, Geeta Mandava, Elin Lavonen, et al.
Current Medical Research and Opinion|June 27, 2022
Are we there yet? Increasing use of cardioprotective antihyperglycemic agents in patients with T2D and CVD or CV risk in the United StatesReema Mody, Juliana Meyers, Maria Yu, et al.
Acta Parasitologica|March 1, 2024
Comparative Analysis of Parasite Load on Recently Established Invasive Pumpkinseed Lepomis gibbosus (Actinopterygii: Centrarchidae) in EuropeIvanna Dudliv, Yuriy Kvach, Maria Yu Tkachenko, et al.
Parasitology Research|August 17, 2021
The role of the non-indigenous pumpkinseed Lepomis gibbosus (Actinopterygii: Centrarchidae) in the life cycle of Bothriocephalus claviceps (Cestoda: Bothriocephalidae) in EuropeYuriy Kvach, Maria Yu Tkachenko, Veronika Bartáková, et al.
Clinical Therapeutics|November 24, 2007
Assessing compliance, acceptance, and tolerability of teriparatide in patients with osteoporosis who fractured while on antiresorptive treatment or were intolerant to previous antiresorptive treatment: an 18-month, multicenter, open-label, prospective studyJonathan D Adachi, David A Hanley, Joanne K Lorraine, et al.
Diabetes, Obesity & Metabolism|August 1, 2019
Effect of once-weekly dulaglutide versus insulin glargine in people with type 2 diabetes and different baseline glycaemic patterns: A post hoc analysis of the AWARD-2 clinical trialFrancesco Giorgino, Maria Yu, Axel Haupt, et al.
Pageof 10